CAS 2118356-96-8

CDK9 PROTAC compound 3

CAS : 2118356-96-8

Formule : C₃₃H₃₅N₅O₇

Degré de pureté : 99%

Masse moléculaire : 613.6603

Ref: IN-DA01EO8Z

PROTAC CDK9 Degrader-1

CAS : 2118356-96-8

PROTAC CDK9 Degrader-1

Degré de pureté : ≥95%

Masse moléculaire : 613.66g/mol

Ref: 54-BUP21143

PROTAC CDK9 Degrader-1

CAS : 2118356-96-8

PROTAC CDK9 Degrader-1 is a selective PROTAC-based CDK9 degrader, composed of a Cereblon ligand and a CDK ligand.

Formule : C₃₃H₃₅N₅O₇

Degré de pureté : 95.1%

Couleur et forme : Solid

Masse moléculaire : 613.66

Ref: TM-T5438

PROTAC CDK9 Degrader-1

CAS : 2118356-96-8

PROTAC CDK9 Degrader-1 is a combination therapy that includes two different types of drugs. One drug inhibits the activity of cyclin-dependent kinases (CDKs). The other drug inhibits the activity of autophagy enzymes. Together, these drugs inhibit the growth of cancer cells and are currently being investigated as a treatment for leukemia and lymphoma in human patients.

Formule : C₃₃H₃₅N₅O₇

Degré de pureté : Min. 95%

Masse moléculaire : 613.66 g/mol

Ref: 3D-TJD35696